Læknaneminn - 01.10.1996, Qupperneq 63

T
G 3
'-U.
U L C C .7 O O L C L CL
3 0 M.
Helicobacter pylori - yfirlitsgrein
36. Carrick J, Lee A, Hazell S, Ralston M, Daskalopoulos G:
Campylobacter pylori, doudenal ulcer, and gastric metaplasia: possi-
ble role of functional heterotopic tissue in ulcerogenesis. Gut 1989,
30:790-797
37. Hupertz V, Czinn S: Demonstration of a cytotoxin from
Campylobacter pylori. Eur J Clin Microbiol Infect Dis 1988,7:
38. Thomas JE, Whatmore AM, Barrer MR et al: Serodiagnosis of
Helicobacter infection in children. J Clin Microbio 1990, 28:2641-
2646
39. Awakawa T, Sugiyama T, Sisano K, Karita M, Yachi A: Detection
and identification of cagA of Helicobacter pylori by polymerase
chain reaction. Eur J Gastroenterol Hepatol 1995, 7 Suppl 1:S75-
78
40. Husson MO, Gottrand F, Vachee A, Dhaenens L, de la Salle Em,
Turck D, Houcke M, Leclerc H: Importance of diagnosis of gastrit-
is of detection by PCR of the cagA gene in Helicobacter pylori stra-
ins isolated from children. J Clin Microbiol 1995, 33(12)3300-
3303
41. Graham D: Helicobacter pylori: its epidemiology and its role in
duodenal ulcer disease. J Gastroenterol Hepatol 1991. 6:105-113
42. Stolte M, Eidt S: Lymphoid follicles of the antral mucosa: immune
reaction to Campylobacter pylori? J Clin Pathol 1989, 42:1269-
1271
43. Drumm NB: Helicobacter pylori in the pediatric patient. Gastro
Clin North Am 1993, 22:169
44. Hassall E, Dimmick JE: Unique features of Helicobacter pylori
disease in children. Dig Dis Sci 1991, 36:417
45. Davies GR, Simmonds NJ, Stevens Tjr, Sheaff MT, Banatvala N,
Laurenson IF, Blake DR, Rampton DS: Helicoabcter pylori stimu-
lates antral mucosal reactive oxygen metabolite production in vivo.
Gut 1993, 35:179-185
46. Witteman EM, Mravunac M, Becx MJ, Hopman WP, Verschoor JS,
Tytgat GN, De Koning RW: Improvement of gastric inflammation
and resolution of epithelial damage one year after eradication of
Helicobacter pylori. J Clin Pathol 1995, 48(3):250-256
47. Khulusi S, Mendall MA, Badve S, Patel P, Finlayson C, Northfield
TC: Effect of Helicobacter pylori eradication on gastric metaplasia
of the duodenum. Gut 1995, 36(2): 193-197
48. Hamlet A, Dalenback J, Olbe L, Fandriks L: Does antral distension
inhibit gastric acid secretion or stimulate bicarbonate secretion in
“healthy” subjects? Scand J Gastroenterol 1993, 28:999-1004
49. Peterson W, Batnett CC, Evans DJ, Feldman M, CarmodyT, Ric-
hardson C, Walsh J, Graham DY: Acid secretion and serum gastrin
in normal subjects and patients with doudenal ulcer: the role of
Helicobacter pylori. Am J Gastroenterol 1993, 88:2038-2043
50. Tarnasky PR, KovacsTOG, Sytnik B, Walsh JH: Asymptomatic H.
pylori infection impairs pH inhibition of gastrin and acid secretion
during second hour of peptone meal stimulation. Di Dis Sci 1993,
38:1681-1687
51. El-Omar E, Penman I, Dorrian CA, Ardill JES, McColl KEL: Era-
dicating Helicobacter pylori infection lowers gastrin mediated acid
secretion by two thirds in patients with duodenal ulcer. Gut 1993,
34:1060-1065
52. Mulholland G, Ardill JES, Fillmore D, Chittajallu RS, Fullarto
GM, McColl KEL: Helicobacter pylori related hypergastrinaemia is
the result of a selective increase in gastrin 17. Gut 1993, 34:757-
761
53. Graham DY, Lew GM, Lechago J: Antral G-cell and D-cell num-
bers in Helicobacter pylori infection: Effect of H. pylori erad-
ication. Gastroenterology 1993, 104:1655-1660
54. Moss SF, Legon S, Bishop AE, Polak JM, Calam J: Effect of Helic-
obacter pylori on Gastric somatostatin un duodenal ulcer disease.
Lancet 1992, 340:930-932
55. Moss S, Calam J: Acid secretion and sensitivity to gastrin in pati-
ents with duodenal ulcer: Effect of eradication of Helicobacter
pylori. Gut. 1993, 34:888-892
56. Caballero-Plasencia AM, Muros-Navarro MC, Martin-Ruiz JL, Val-
enzuela-Barranco M, de los Reyes-Garcia MC, Casado-Caballero
FJ, Rodriguez-Tellez M, Lopez-Manas JG: Dyspeptic symptoms
and gastric emptying of solids in patients with functional dyspepsia.
Role of Helicobacter pylori infection. Scand J Gastroenterol 1995,
30(8):745-751
57. Karita M, Li Q, Cantero D, Okita K: Establishment of a small ani-
mal model for human Helicobacter pylori infection using germ-free
mouse. Am J Gastroenterol 1994, 89(2):208-213
58. Sherburne R, Taylor DE: Helicobacter pylori express a complex sur-
face carbohydrate, Lewis X. Infection & Immunity 1995,
63(12):4564-4568
59. Azuma T, Konishi J, Tanaka Y et al: Contribution of HLA-DQa
gene to host's response against Helicobacter pylori. Lancet 1994,
343:542
60. Blaser MJ, Chyou PH, Nomura A: Age at establishment of Helic-
obacter pylori infection and gastric carcinoma, gastric ulcer, and
duodenal ulcer risk. Cancer Research 1995, 55(3):562-565
61. Guarner J, Mohar A, Parsonnet J, Halperin D: The association of
Helicobacter pylori with gstric cancer and preneoplastic gastric les-
ion in Chipas, Mexico. Cancer 1993, 71:297-301
62. Eidt S, Forman D, Stolte M: The year in Helicobacter pylori 1994
- Gastric malignancies. Current science Ltd. 1995 41-45
63. Niemela S, Karttunen, Kerola T, Karttunen R: Ten year follow up
study of lymphocytic gastritis: further evidence on Helicobacter
pylori as a cause of lymphocytic gastritis and corpus gastritis. J Clin
Pathol 1995, 48(12):1111-1116
64. Wotherspoon AC, Doglioni C, DissTC, Pan L, Moschini A, deBoni
M, Isaacson PG: Regression of primary low-grade B-cell lymphoma
of mucosa-associated lymphoid tissue type after eradication of
Helicobacter pylori. Lancet 1993, 342:575-557
65. Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A,
Pedrinis E, Paterlini A, Venco A, Cavalli F: Eradication of Helic-
obacter pylori infection in primary low-grade gastric lymphoma of
mucosa-associated lymphoid tissue. Ann Int Med, 1995,
122(10):767-9.
66. Carlson SJ, Yokoo H, Vanagunas A: Progression of gastritis to mon-
oclonal B-cell lymphoma with resolution and recurrence followint
eradication of Helicobacter pylori. JAMA 1996, 275(12):937-939
67. Blecker U, McKeithan TW, Hart J, Kirschner BS: Resolution of
Helicobacter pylori-associated gastric lymphoprolipherative disease
in a child. Gastroenterology 1995, 109(3):973-977
68. Davies GR, Simmonds NJ, Stevens Tjr, Sheaff MT, Banatvala N,
Laurenson IF, Blake DR, Rampton DS: Helicoabcter pylori stimu-
lates antral mucosal reactive oxygen metabolite production in vivo.
Gut 1993, 35:179-185
69. Rokkas T, Papatheodorou G, Karameris A, Mavrogeorgis A,
Kalogeropoulos N, Giannikos N: Helicobacter pylori infection and
gastric juice vitamin C levels. Impact of eradication. Dig Dis Sci
1995, 40(3):615-621
70. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strach-
an D, Camm AJ, Northfield TC: Relation of Helicobacter pylori
infection and coronary heart disease. Br Heart J 1994, 71:437-439
71. Reinauer S, Megahed M, Goerz G, RuzicaT, Brochard F, Susanto F,
Reinauer H: Schonlein-henoch purpura associated with gastric
Helicobacter pylori infection. J Am Acad Derm 1995,
33(5Pt2):786-789
72. Lin TT, Yeh CT, Wu CS, Liaw YF: Detection and partial sequence
analysis of Helicobacter pylori DNA in the bile samples. Dig Dis
Sci 1995, 40( 10):2214-2219
73. Fréttatilkynning, European Helicobacter pylori study group: New
European recommendations for eradication of Helicobacter pylori
launched following consensus conference. Kynnt á IX.
International workshop on gastrodoudenal pathology and Helic-
obacter pylori, Kaupmannahöfn október 1996.elicobacter pylori
HeaHleir
74. Soll AH: Conensus conference. Medical treatment of peptic ulcer
disease. Practice guidelines. Practice Parameters Committee of th
American College of Gastroenterology. JAMA 1996, 275(8):622-
629
75. McCarthy C, Patchett S, Collins RM, Beattie S, Keane C, O'Mora-
in C: Long-term prospective study of Helicobacter pylori in nonul-
cer dyspepsia. Dig Dis Sci. 1995,40(1)114-119.
76. Agreus L, Engstrand L, Svarsudd K, Nyren O, Tibblin G: Helic-
obacter pylori seropositivity among Swedish adults with and wit-
hout abdominal symptoms. A population-based epideiologic study.
Scand J Gastroenterol 1995, 30(8):752-Scand J Gastroenterol 1996,
31/Suppl 217:26.
LÆKNANEMINN
53
2. tbl. 1996, 49. árg.